What are the differences between glaucoma and cataract regarding symptoms, diagnosis, and treatment?

Glaucoma vs Cataract: Key Differences

Glaucoma and cataract are fundamentally different diseases—glaucoma is a chronic, progressive optic neuropathy causing irreversible vision loss through optic nerve damage, while cataract is a reversible degradation of the lens that affects optical quality but can be surgically corrected.

Disease Definitions

Glaucoma

Primary open-angle glaucoma (POAG) is a chronic, progressive optic neuropathy characterized by acquired atrophy of the optic nerve and loss of retinal ganglion cells and their axons 1. This is a potentially blinding disease that, critically, causes irreversible vision loss. The disease is generally bilateral but often asymmetric, and approximately 40% of patients have intraocular pressure (IOP) consistently within the normal range 1.

Cataract

Cataract is a degradation of the optical quality of the crystalline lens that affects vision, most commonly related to aging 2. Unlike glaucoma, this represents a reversible cause of vision loss through surgical intervention.

Symptoms: How to Distinguish Clinically

Glaucoma Symptoms

Patients with glaucoma characteristically report:

• Poor peripheral vision (most distinctive feature)
• Missing patches in vision
• Better vision in one eye compared to the other
• Light sensitivity
• Impaired driving (especially at night), reading speed, and outdoor mobility in advanced cases 1, 3

Critical pitfall: Glaucoma is often asymptomatic in early stages, making screening essential for at-risk populations.

Cataract Symptoms

Patients with cataract typically report:

• Progressive worsening of vision (most distinctive feature)
• Glare symptoms (especially with cortical and posterior subcapsular types)
• Light sensitivity
• Difficulty with bright light
• Near vision more affected than distance (particularly with posterior subcapsular cataract) 2, 3

A 2023 study found that asking about visual symptoms can distinguish these conditions: compared to glaucoma suspects, glaucoma patients were 11 times more likely to report poor peripheral vision, while cataract patients were 12 times more likely to report worsening vision 3.

Diagnosis: Specific Examination Findings

Glaucoma Diagnosis Requires 1:

Optic nerve damage evidence:

• Diffuse or focal narrowing/notching of optic disc rim (especially inferior or superior poles)
• Progressive neuroretinal rim narrowing with increased cupping
• Optic disc hemorrhages
• Thinning of retinal nerve fiber layer (RNFL) and/or macula on imaging
• Beta-zone parapapillary atrophy

Visual field abnormalities:

• Nasal step, arcuate defect, or paracentral depression
• Visual field loss across horizontal midline in one hemifield exceeding the opposite
• Consistent with RNFL damage pattern

Gonioscopy: Open anterior chamber angles

IOP measurement: May be elevated or normal

Additional testing:

• Central corneal thickness (CCT) measurement
• Computer-based imaging (OCT, HRT, GDx)
• Stereoscopic photography

Cataract Diagnosis Requires 2:

Slit-lamp biomicroscopy identifying:

• Nuclear cataract: central opacification/discoloration (brunescent or opalescent)
• Cortical cataract: opaque spokes or oil droplets appearance
• Posterior subcapsular cataract: opacity just inside posterior lens capsule

Assessment of:

• Visual acuity impact
• Effect on quality of life and functional activities
• Presence of coexisting ocular disease

Important caveat: Cataract can interfere with glaucoma diagnostic testing—imaging quality is reduced preoperatively, and new baseline measurements should be obtained after cataract surgery 4.

Treatment: Fundamentally Different Approaches

Glaucoma Treatment 1:

Goal: Lower IOP to prevent progression (even in normal-tension glaucoma, lowering pressure is beneficial)

Target IOP reduction: 20-30% below baseline, adjusted based on disease severity and progression

Treatment options:

1. Medical therapy: IOP-lowering medications (first-line)
2. Laser therapy: Selective laser trabeculoplasty
3. Incisional surgery: Trabeculectomy, glaucoma drainage devices, minimally invasive glaucoma surgery (MIGS)

Critical point: Treatment is lifelong and aims to slow progression, not restore lost vision.

Cataract Treatment 2:

Symptomatic cataract is a surgical disorder—dietary supplements and nutritional interventions have minimal effect 2.

Standard approach:

• Small-incision phacoemulsification with foldable IOL implantation (outpatient basis)
• Surgery performed when it will enhance patient function and the informed patient elects this option
• Timing based on mutual agreement between patient and surgeon

Important benefit: Cataract surgery can independently lower IOP, which may benefit glaucoma patients 5.

Management of Coexisting Conditions

When both conditions coexist (common in elderly patients), the decision between combined surgery versus cataract surgery alone is complex 5, 6:

Combined cataract and glaucoma surgery:

• Results in greater IOP reduction (mean difference -1.62 mmHg at one year) 5
• Reduces medication burden by approximately one medication 5
• Patients 50% less likely to require IOP-lowering medications postoperatively 5

Cataract surgery alone:

• May independently lower IOP
• Fewer surgical complications
• More predictable refractive outcomes

MIGS procedures offer a middle ground: effective IOP reduction with better safety profiles and more predictable refractive results when combined with cataract surgery 2, 6.

Critical consideration: Cataract significantly impacts quality of life in glaucoma patients of all severity levels and represents a potentially reversible cause of visual impairment 7. The decision should prioritize which condition is causing greater functional impairment.

Risk Factors to Screen For

Glaucoma Risk Factors 1:

• Older age
• African race or Latino/Hispanic ethnicity
• Elevated IOP
• Family history of glaucoma
• Low ocular perfusion pressure
• Type 2 diabetes mellitus
• Myopia
• Thin central cornea

Cataract Risk Factors 2:

• Advancing age (risk increases each decade after age 40)
• Corticosteroid use
• Diabetes
• Trauma
• Uveitis

Medicare covers glaucoma screening for beneficiaries with diabetes, family history of glaucoma, African Americans ≥50 years, and Hispanics ≥65 years 1.